Hercules Capital, Inc. provided its interim portfolio update for the fourth quarter 2016.
 
“Our fourth quarter-to-date portfolio activity reflects another strong quarter of new origination and funding activities, closing over $200 million of new commitments, adding seven new innovative venture growth stage technology and life sciences companies, backed by some of the leading venture capital firms in the U.S., to our portfolio,” stated Manuel A. Henriquez, chairman and chief executive officer of Hercules. “Year-to-date 2016, we have closed over $800 million in new commitments to new and existing portfolio companies, surpassing our 2015 new commitments of $745 million, highlighting the success of our origination team in executing our portfolio growth strategy.”

Henriquez concluded, “In addition, we witnessed several portfolio companies successfully achieving critical key performance milestones in the fourth quarter, which unlocked unfunded commitments, further fueling the growth of our debt investment portfolio balance. As a result of this strong execution, Hercules is on a pace to potentially exceed the high end of our desired full year debt investment portfolio target of $1.35 billion.”